Position history for BlackRock, Inc.'s holdings in NEUROCRINE BIOSCIENCES INC
BlackRock, Inc. holds 13.4M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $1.8B as of 2026-Q1. The position was increased (+4.3% shares). NBIX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$1.8B
Current Shares
13.4M
Total Value Change
-$254.4M
Total Shares Change
-1.4M
Other major holders of NBIX: BlackRock Finance, Inc., VANGUARD GROUP INC
Increased |
| 13.4M |
+4.3% |
| $1.8B |
| 0.0% |
| $131.14 |
33 |
| 2025-Q4 | Increased | 12.8M | +1.0% | $1.8B | 0.0% | $140.95 | 32 |
| 2025-Q3 | Decreased | 12.7M | -1.9% | $1.8B | 0.0% | $140.27 | 0 |
| 2025-Q2 | Decreased | 13M | -11.8% | $1.6B | 0.0% | $125.42 | 0 |
| 2025-Q1 | Decreased | 14.7M | -0.7% | $1.6B | 0.0% | $113.16 | 0 |
| 2024-Q4 | New | 14.8M | - | $2B | 0.0% | $137.06 | 44 |